|
|
||||||||
From the Magnetic Resonance Unit (Drs. Schuff, Amend, Tanabe, and Weiner, and S.K. Steinman), and Psychiatry Research (Dr. Fein and F. Ezekiel), Department of Veterans Affairs Medical Center, San Francisco, the Departments of Radiology (Drs. Schuff, Tanabe, Norman, Fein, and Weiner, and S.K. Steinman), Psychiatry (Drs. Kramer, Fein, and Weiner), and Neurology (Drs. Mastrianni and Weiner), University of California, San Francisco; the Center for Functional Imaging (Dr. Jagust), Lawrence Berkeley Laboratory, and the Department of Neurology (Dr. Jagust), University of California, Davis, CA.
Address correspondence and reprint requests to Dr. Norbert Schuff, DVA Medical Center, MR Unit, 4150 Clement Street, 114M, San Francisco, CA 94121.
Hippocampal atrophy detected by MRI is a prominent feature of early Alzheimer's disease (AD), but it is likely that MRI underestimates the degree of hippocampal neuron loss, because reactive gliosis attenuates atrophy. We tested the hypothesis that hippocampal N-acetyl aspartate (NAA; a neuronal marker) and volume used together provide greater discrimination between AD and normal elderly than does either measure alone. We used proton MR spectroscopic imaging (1H MRSI) and tissue segmented and volumetric MR images to measure atrophy-corrected hippocampal NAA and volumes in 12 AD patients (mild to moderate severity) and 17 control subjects of comparable age. In AD, atrophy-corrected NAA from the hippocampal region was reduced by 15.5% on the right and 16.2% on the left (both p<0.003), and hippocampal volumes were smaller by 20.1% (p<0.003) on the right and 21.8% (p <0.001) on the left when compared with control subjects. The NAA reductions and volume losses made independent contributions to the discrimination of AD patients from control subjects. When used separately, neither hippocampal NAA nor volume achieved to classify correctly AD patients better than 80%. When used together, however, the two measures correctly classified 90% of AD patients and 94% of control subjects. In conclusion, hippocampal NAA measured by 1H MRSI combined with quantitative measurements of hippocampal atrophy by MRI may improve diagnosis of AD.
Supported by NIH grant R01AG10897 (M.W.W), NIH grant AG10129 (W.J.), and NIH/NIA grant P01AG12435 (M.W.W.). Additional support is acknowledged from the DVA Medical Research Service (M.W.W.), a DVA Research Career Scientific Award (G.F.), and an Individual Research Service Award NIH AG05759-02(D.A.).
Received February 19, 1997. Accepted in final form July 9, 1997.
This article has been cited by other articles:
![]() |
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review American Journal of Alzheimer's Disease and Other Dementias, April 1, 2009; 24(2): 95 - 121. [Abstract] [PDF] |
||||
![]() |
K. G. King, L. Glodzik, S. Liu, J. S. Babb, M. J. de Leon, and O. Gonen Anteroposterior Hippocampal Metabolic Heterogeneity: Three-dimensional Multivoxel Proton 1H MR Spectroscopic Imaging--Initial Findings Radiology, October 1, 2008; 249(1): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kantarci, D. S. Knopman, D. W. Dickson, J. E. Parisi, J. L. Whitwell, S. D. Weigand, K. A. Josephs, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr Alzheimer Disease: Postmortem Neuropathologic Correlates of Antemortem 1H MR Spectroscopy Metabolite Measurements Radiology, July 1, 2008; 248(1): 210 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K KANTARCI 1H Magnetic resonance spectroscopy in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S146 - S152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Minati, M. Grisoli, and M. G. Bruzzone MR Spectroscopy, Functional MRI, and Diffusion-Tensor Imaging in the Aging Brain: A Conceptual Review J Geriatr Psychiatry Neurol, March 1, 2007; 20(1): 3 - 21. [Abstract] [PDF] |
||||
![]() |
C. R. Jack Jr, M. Marjanska, T. M. Wengenack, D. A. Reyes, G. L. Curran, J. Lin, G. M. Preboske, J. F. Poduslo, and M. Garwood Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research Neuroscientist, February 1, 2007; 13(1): 38 - 48. [Abstract] [PDF] |
||||
![]() |
L. L. Chao, N. Schuff, J. H. Kramer, A. T. Du, A. A. Capizzano, J. O'Neill, O. M. Wolkowitz, W. J. Jagust, H. C. Chui, B. L. Miller, et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients Neurology, January 25, 2005; 64(2): 282 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Du, N. Schuff, J. H. Kramer, S. Ganzer, X. P. Zhu, W. J. Jagust, B. L. Miller, B. R. Reed, D. Mungas, K. Yaffe, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD Neurology, February 10, 2004; 62(3): 422 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Driscoll, D. A. Hamilton, H. Petropoulos, R. A. Yeo, W. M. Brooks, R. N. Baumgartner, and R. J. Sutherland The Aging Hippocampus: Cognitive, Biochemical and Structural Findings Cereb Cortex, December 1, 2003; 13(12): 1344 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schuff, A.A. Capizzano, A.T. Du, D.L. Amend, J. O'Neill, D. Norman, W.J. Jagust, H.C. Chui, J.H. Kramer, B.R. Reed, et al. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD Neurology, August 12, 2003; 61(3): 358 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Deicken, M. P. Pegues, S. Anzalone, R. Feiwell, and B. Soher Lower Concentration of Hippocampal N-Acetylaspartate in Familial Bipolar I Disorder Am J Psychiatry, May 1, 2003; 160(5): 873 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Spencer, T. Zitzelberger, D. Spielman, and J. Kaye MRS in relation to hippocampal volume in the oldest old Neurology, April 8, 2003; 60(7): 1194 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Dixon, K. M. Bradley, M. M. Budge, P. Styles, and A. D. Smith Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease Brain, October 1, 2002; 125(10): 2332 - 2341. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Drachman Hat size, brain size, intelligence, and dementia: What morphometry can tell us about brain function and disease Neurology, July 23, 2002; 59(2): 156 - 157. [Full Text] [PDF] |
||||
![]() |
W. Block, F. Jessen, F. Traber, S. Flacke, C. Manka, R. Lamerichs, E. Keller, R. Heun, and H. Schild Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease Arch Neurol, May 1, 2002; 59(5): 828 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Mega, G. W. Small, M. L. Xu, J. Felix, M. Manese, N. P. Tran, J. I. Dailey, L. M. Ercoli, S. Y. Bookheimer, and A. W. Toga Hippocampal Atrophy in Persons With Age-Associated Memory Impairment: Volumetry Within a Common Space Psychosom Med, May 1, 2002; 64(3): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schuff, A. A. Capizzano, A. T. Du, D. L. Amend, J. O'Neill, D. Norman, J. Kramer, W. Jagust, B. Miller, O. M. Wolkowitz, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD Neurology, March 26, 2002; 58(6): 928 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.J.A. Callen, S.E. Black, F. Gao, C.B. Caldwell, and J.P. Szalai Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD Neurology, November 13, 2001; 57(9): 1669 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A T Du, N Schuff, D Amend, M P Laakso, Y Y Hsu, W J Jagust, K Yaffe, J H Kramer, B Reed, D Norman, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kizu, K. Yamada, and T. Nishimura Proton Chemical Shift Imaging in Normal Pressure Hydrocephalus AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sencakova, N. R. Graff-Radford, F. B. Willis, J. A. Lucas, F. Parfitt, R. H. Cha, P. C. O'Brien, R. C. Petersen, and C. R. Jack Jr Hippocampal Atrophy Correlates With Clinical Features of Alzheimer Disease in African Americans Arch Neurol, October 1, 2001; 58(10): 1593 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bozzali, M. Franceschi, A. Falini, S. Pontesilli, M. Cercignani, G. Magnani, G. Scotti, G. Comi, and M. Filippi Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI Neurology, September 25, 2001; 57(6): 1135 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jessen, W. Block, F. Traber, E. Keller, S. Flacke, R. Lamerichs, H. H. Schild, and R. Heun Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients Neurology, September 11, 2001; 57(5): 930 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF] |
||||
![]() |
W. Huang, G. E. Alexander, L. Chang, H. U. Shetty, J. S. Krasuski, S. I. Rapoport, and M. B. Schapiro Brain metabolite concentration and dementia severity in Alzheimer's disease: A 1H MRS study Neurology, August 28, 2001; 57(4): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Hsu, M.-C. Chen, K.-E. Lim, and C. Chang Reproducibility of Hippocampal Single-Voxel Proton MR Spectroscopy and Chemical Shift Imaging Am. J. Roentgenol., February 1, 2001; 176(2): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Angelie, A. Bonmartin, A. Boudraa, P.-M. Gonnaud, J.-J. Mallet, and D. Sappey-Marinier Regional Differences and Metabolic Changes in Normal Aging of the Human Brain: Proton MR Spectroscopic Imaging Study AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jessen, W. Block, F. Traber, E. Keller, S. Flacke, A. Papassotiropoulos, R. Lamerichs, R. Heun, and H. H. Schild Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD Neurology, September 12, 2000; 55(5): 684 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kantarci, C. R. Jack Jr., Y. C. Xu, N. G. Campeau, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. Kokmen, E. G. Tangalos, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study Neurology, July 25, 2000; 55(2): 210 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Capizzano, N. Schuff, D. L. Amend, J. L. Tanabe, D. Norman, A. A. Maudsley, W. Jagust, H. C. Chui, G. Fein, M. R. Segal, et al. Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and 1H MR Spectroscopy AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 621 - 630. [Abstract] [Full Text] |
||||
![]() |
P. Vermathen, K. D. Laxer, G. B. Matson, and M. W. Weiner Hippocampal Structures: Anteroposterior N-acetylaspartate Differences in Patients with Epilepsy and Control Subjects as Shown with Proton MR Spectroscopic Imaging Radiology, February 1, 2000; 214(2): 403 - 410. [Abstract] [Full Text] |
||||
![]() |
C. M. Moore, B. deB. Frederick, and P. F. Renshaw Brain Biochemistry Using Magnetic Resonance Spectroscopy: Relevance to Psychiatric Illness in the Elderly J Geriatr Psychiatry Neurol, October 1, 1999; 12(3): 107 - 117. [Abstract] [PDF] |
||||
![]() |
T. M. Rudkin and D. L. Arnold Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders Arch Neurol, August 1, 1999; 56(8): 919 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pfefferbaum, E. Adalsteinsson, D. Spielman, E. V. Sullivan, and K. O. Lim In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease Arch Gen Psychiatry, February 1, 1999; 56(2): 185 - 192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |